• Overview

Or call us on

020 8247 3351
Overall rating Good

Lutetium-177 PSMA therapy is a new treatment for prostate cancer. It uses targeted radiation to kill cancer cells while sparing healthy tissues, even those resistant to other treatments.

What is Lutetium-177-PSMA therapy?

Lutetium-177 PSMA therapy is an innovative treatment for metastatic prostate cancer. It takes advantage of the presence of a specific receptor on the prostate cancer cell surface (PSMA, prostate-specific membrane antigen) and delivers targeted lethal radiation directly to the cancer cells. This means the treatment has minimal toxicity to other organs. As Lutetium-177 kills cancer cells through targeted high-dose radiation, it can be effective even in cancers which become resistant to other treatments such as hormones or chemotherapy.

Is Lutetium-177 PSMA therapy right for me?

Lutetium-177-PSMA therapy is a treatment for advanced prostate cancer. Your consultant may recommend Lutetium-177-PSMA therapy if:

  • You have already had chemotherapy or cannot have chemotherapy
  • You have already tried other hormonal therapies
  • Your cancer is resistant to other treatments

What are the benefits of Lutetium-177 PSMA therapy? 

Lutetium-177 PSMA therapy is beneficial for patients with advanced prostate cancer. It can reduce symptoms, improve qualify of life and extend life expectancy.

What happens during Lutetium-177 PSMA therapy?

The treatment is given by an experienced team consisting of doctors, nurses, nuclear medicine technologists, pharmacists, and medical physicists.

Lutetium-177 PSMA therapy is given as a drip into your hand or arm vein. It takes about 20 minutes and has no immediate side effects. We will ask you to drink plenty of water before and afterwards.

You will have between three and six treatments, at 6 to 8-week intervals. It is usually given as an outpatient procedure.

What are the side effects of Lutetium-177 PSMA therapy?

Possible side effects of Lutetium-177 PSMA therapy may include fatigue, nausea, dry mouth, and temporary reduction in blood cell counts. In some cases, there may be mild kidney or liver effects. However, these side effects are typically manageable and temporary, and the therapy's benefits often outweigh the side effects.

Cancer Centre London – Trailblazers

Starting in 2019, Cancer Centre London is one of the very few centres which pioneered this treatment in the UK. The treatment is supported and overseen by top experts of our Uro-Oncology MDT. Lead clinician Dr Yong Du (Consultant Physician in Nuclear Medicine) is the first doctor in the UK to be certified to give this treatment to patients. Using his extensive experience in both diagnostic and therapeutic nuclear medicine procedures (including PET/CT and radionuclide-targeted therapy), he has treated over 200 patients with Lu-177-PSMA (more than any UK doctor).

Find out more about Lutetium-177 PSMA therapy

Lutetium-177 PSMA therapy consultants at Cancer Centre London

Cancer Centre London

49 Parkside, Wimbledon, London, SW19 5NB

020 8247 3351
Outpatient appointments 020 8247 3379 /3380
Patient liaison / Finance 020 8247 3406
Chemotherapy 020 8247 3369 /3419
Radiotherapy 020 8247 3436
CT Planning 020 8247 3412
Physics 020 8247 3414
Pharmacy 020 8247 3367
Physiotherapy 020 8247 3402
Complementary Therapy 020 8247 3401
Nuclear Medicine 020 8247 3428

Ways to pay

Nuffield Health promise

Our prices are all-inclusive. We will equal any comparable price. There are no time limits on your aftercare.

Paying for yourself

There are no hidden costs in our treatment prices. The price you see is the price you pay.

Find out more

Personal medical loan

Spread the cost of your treatment with a 6, 10 or 12 month 0% personal medical loan.

Find out more

Medical insurance

We work with you and your insurance provider to get you the treatment you need quickly

Find out more